Tham khảo Fluoxymesterone

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 William Llewellyn (2011). Anabolics. Molecular Nutrition Llc. tr. 500–508. ISBN 978-0-9828280-1-4. 
  2. 1 2 Thomas L. Lemke; David A. Williams (24 tháng 1 năm 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. tr. 1360–. ISBN 978-1-60913-345-0. 
  3. 1 2 3 4 Kammerer RC, Merdink JL, Jagels M, Catlin DH, Hui KK (1990). “Testing for fluoxymesterone (Halotestin) administration to man: identification of urinary metabolites by gas chromatography-mass spectrometry”. J. Steroid Biochem. 36 (6): 659–66. PMID 2214783. doi:10.1016/0022-4731(90)90185-u. 
  4. 1 2 Seth Roberts (2009). Anabolic Pharmacology.
  5. ↑ Thomas L. Lemke; David A. Williams (2008). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. tr. 1279–. ISBN 978-0-7817-6879-5. 
  6. 1 2 3 4 5 6 Fürstenberger C, Vuorinen A, Da Cunha T, Kratschmar DV, Saugy M, Schuster D, Odermatt A (2012). “The anabolic androgenic steroid fluoxymesterone inhibits 11β-hydroxysteroid dehydrogenase 2-dependent glucocorticoid inactivation”. Toxicol. Sci. 126 (2): 353–61. PMID 22273746. doi:10.1093/toxsci/kfs022. 
  7. 1 2 3 4 Joseph JF, Parr MK (2015). “Synthetic androgens as designer supplements”. Curr Neuropharmacol 13 (1): 89–100. PMC 4462045. PMID 26074745. doi:10.2174/1570159X13666141210224756. 
  8. ↑ Kicman AT (2008). “Pharmacology of anabolic steroids”. Br. J. Pharmacol. 154 (3): 502–21. PMC 2439524. PMID 18500378. doi:10.1038/bjp.2008.165. 
  9. 1 2 3 Charles D. Kochakian (6 tháng 12 năm 2012). Anabolic-Androgenic Steroids. Springer Science & Business Media. tr. 370,374,401,454,504–506. ISBN 978-3-642-66353-6. 
  10. 1 2 William Andrew Publishing (22 tháng 10 năm 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. tr. 1676–. ISBN 978-0-8155-1856-3. 
  11. ↑ Susan M. Ford; Sally S. Roach (7 tháng 10 năm 2013). Roach's Introductory Clinical Pharmacology. Lippincott Williams & Wilkins. tr. 502–. ISBN 978-1-4698-3214-2. 
  12. ↑ http://adisinsight.springer.com/drugs/800012288
  13. ↑ Jerome Z. Litt; Neil Shear (17 tháng 12 năm 2014). Litt's Drug Eruptions and Reactions Manual, 19th Edition. CRC Press. tr. 177–. ISBN 978-1-84214-599-9. 
  14. 1 2 3 4 5 Kicman, A T (2008). “Pharmacology of anabolic steroids”. British Journal of Pharmacology 154 (3): 502–521. PMC 2439524. PMID 18500378. doi:10.1038/bjp.2008.165. 
  15. ↑ Attardi BJ, Pham TC, Radler LC, Burgenson J, Hild SA, Reel JR (2008). “Dimethandrolone (7alpha,11beta-dimethyl-19-nortestosterone) and 11beta-methyl-19-nortestosterone are not converted to aromatic A-ring products in the presence of recombinant human aromatase”. J. Steroid Biochem. Mol. Biol. 110 (3–5): 214–22. PMC 2575079. PMID 18555683. doi:10.1016/j.jsbmb.2007.11.009. 
  16. ↑ Norman T. Adler; Donald Pfaff; Robert W. Goy (6 tháng 12 năm 2012). Reproduction. Springer Science & Business Media. tr. 630–. ISBN 978-1-4684-4832-0. 
  17. ↑ Lo TE, Andal ZC, Lantion-Ang FL (2015). “Fluoxymesterone-induced gynaecomastia in a patient with childhood aplastic anaemia”. BMJ Case Rep 2015: bcr2014207474. PMC 4434366. PMID 25948845. doi:10.1136/bcr-2014-207474. 
  18. ↑ Kirschbaum J (27 tháng 10 năm 1978). Profiles of Drug Substances, Excipients and Related Methodology. Academic Press. tr. 253–. ISBN 978-0-08-086102-9. 
  19. ↑ Mayer M, Rosen F (1975). “Interaction of anabolic steroids with glucocorticoid receptor sites in rat muscle cytosol”. Am. J. Physiol. 229 (5): 1381–6. PMID 173192. doi:10.1152/ajplegacy.1975.229.5.1381. 
  20. ↑ Saartok T, Dahlberg E, Gustafsson JA (1984). “Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin”. Endocrinology 114 (6): 2100–6. PMID 6539197. doi:10.1210/endo-114-6-2100. 
  21. ↑ Gordan, G. S. (1976). “Cancer in Man”. Trong Kochakian, Charles D. Anabolic-Androgenic Steroids. tr. 499–513. ISBN 978-3-642-66355-0. doi:10.1007/978-3-642-66353-6_16. 
  22. 1 2 3 4 J. Elks (14 tháng 11 năm 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. tr. 568–. ISBN 978-1-4757-2085-3. 
  23. 1 2 3 4 Index Nominum 2000: International Drug Directory. Taylor & Francis. Tháng 1 năm 2000. tr. 461. ISBN 978-3-88763-075-1. 
  24. ↑ Schänzer, Willi; Opfermann, Georg; Donike, Manfred (1 tháng 11 năm 1992). “17-Epimerization of 17α-methyl anabolic steroids in humans: metabolism and synthesis of 17α-hydroxy-17β-methyl steroids”. Steroids 57 (11): 537–550. doi:10.1016/0039-128X(92)90023-3. 
  25. 1 2 I.K. Morton; Judith M. Hall (6 tháng 12 năm 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. tr. 123–. ISBN 978-94-011-4439-1. 
  26. 1 2 3 https://www.drugs.com/international/Fluoxymesterone.html
  27. 1 2 “Drugs@FDA: FDA Approved Drug Products”. United States Food and Drug Administration. Truy cập ngày 17 tháng 12 năm 2016. 
  28. ↑ Steven B. Karch (21 tháng 12 năm 2006). Drug Abuse Handbook, Second Edition. CRC Press. tr. 30–. ISBN 978-1-4200-0346-8. 

Tài liệu tham khảo

WikiPedia: Fluoxymesterone http://www.chemspider.com/Chemical-Structure.6205.... http://www.drugs.com/monograph/fluoxymesterone.htm... http://www.sciencedirect.com/science/article/pii/0... http://adisinsight.springer.com/drugs/800012288 http://www.accessdata.fda.gov/scripts/cder/daf/ //www.ncbi.nlm.nih.gov/pmc/articles/PMC2439524 //www.ncbi.nlm.nih.gov/pmc/articles/PMC2575079 //www.ncbi.nlm.nih.gov/pmc/articles/PMC4434366 //www.ncbi.nlm.nih.gov/pmc/articles/PMC4462045 //www.ncbi.nlm.nih.gov/pubmed/173192